BFM
AMAM

Boothbay Fund Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Boothbay Fund Management’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– – – 1895
2023
Q3 		– Hold
0
– – – 1955
2021
Q3 		– Sell
-13,422
Closed -$263K – 2033
2021
Q2 		$263K Buy
+13,422
New +$263K 0.01% 1204